MedTrace Logo

Oxandrolone Rotator Cuff Trial

NCT03091075 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2026-05-07

No results posted yet for this study

Summary

This study is about healing after a rotator cuff tear repair procedure. We hope to learn if a biologic medication: Oxandrolone, a synthetic derivative of the human hormone Testosterone (the principal male sex hormone and an anabolic steroid), given for 12 weeks following rotator cuff repair, is effective in aiding in the healing process and restoring muscle mass.

Conditions

  • Rotator Cuff Tear

Interventions

DRUG

Oxandrolone

Treatment group will receive Oxandrolone daily for 12 weeks postoperatively

DRUG

Placebo

Placebo group will receive placebo for 12 weeks postoperative

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • George R Hatch, MD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-23
Primary Completion
2026-01-06
Completion
2026-01-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03091075 on ClinicalTrials.gov